MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Kasivisvanathan, V.; Rannikko, A.; Borghi, M.; Panebianco, V.; Mynderse, L.; Vaarala, M.; Briganti, A.; Budäus, L.; Hellawell, G.; Hindley, R.; Roobol, M.; Eggener, S.; Ghei, M.; Villers, A.; Bladou, F.; Villeirs, G.; Virdi, J.; Boxler, S.; Robert, G.; Singh, Paras; Venderink, W.; Hadaschik, B.; Ruffion, A.; C Hu, Jim; Margolis, D.; Crouzet, S.; Klotz, L.; Taneja, S.; Pinto, P.; Gill, I.; Allen, C.; Giganti, F.; Freeman, A.; Morris, S.; Punwani, S.; Williams, N.; Brew-Graves, C.; Deeks, J.; Takwoingi, Y.; Emberton, M.; Moore, C.

doi:10.1056/NEJMoa1801993

Public

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Shared by NobleBlocks on Mar 18, 2018 • 12:00 AM UTC

Authors:

V. Kasivisvanathan

A. Rannikko

M. Borghi

Abstract

Background Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography–guided biopsy for prostate‐cancer detection in men with a raised prostate‐specific antigen level who have not undergone biopsy. However, comparative...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!